April 2015

RV longitudinal strain helps detect myocardial fibrosis in HF patients ()
Cognitive decline is common after LVAD implantation ()
Filters offer no added benefit for recurrent pulmonary embolism ()
Boston Scientific collaborates with MedAxiom and TogetherMD to bring value based solutions to healthcare systems ()
Low health literacy associated with increased risk of death in acute HF patients ()
Individual insurance market increases 46% ()
AHA launches guidelines initiative ()
AF is associated with increased risk for non-STEMI ()
CMR may help predict stroke risk in patients with AF ()
Intermittent screening detects 33% more cases of atrial fibrillation ()
Sitagliptin noninferior to placebo in cardiovascular outcomes study ()
Hodgkin lymphoma survivors at high risk of cardiovascular diseases ()
AHA cancels conference in Baltimore ()
Meta-analysis hints at survival benefit with PCSK9 inhibitors ()
Concomitant tricuspid annuloplasty and MV repair is safe and effective ()
A Tip-top Lab of One’s Own ()
Tech & Touch: Keys to Successful Heart Failure Management ()
CEO & HRS Leader’s Strategy: Listen, Ask, Recruit & Step Back ()
How Cardiologists Can Take Advantage of Social Media’s Power ()
It’s a Name Changer: Designation Removes Impediments for Interventional Cardiologists ()
Spying on spyware in implantable devices ()
Success in Heart Failure: Keeping Patients Free of Hospitals ()
FFR & IVUS: Putting Tools to Good Use ()
Stress Test: Evidence Mounts in Regadenoson’s Favor ()
Valves in 3D: Updated Echo Techniques Add Clarity ()
Workflow in the Lab: Going from Stuck to Steady ()
Early discharge after TAVR appears safe, feasible with Sapien XT ()
Similar survival rates for children who receive therapeutic hypothermia or normothermia ()
For many, paying tax is cheaper than purchasing health insurance ()
Physicians, surgeons drop a few pegs in job ratings ()
Coronary CT angiography is cost-effective for patients with stable chest pain ()
FDA grants priority review to Boehringer Ingelheim’s biologics license application for idarucizumab ()
FDA recalls TigerPaw II after reports of tearing ()
Structured Reporting: The Road Map for Better Data, Workflow and Reports ()
Crime & astonishment ()
A safer cath lab ()
Number of ACOs increases, but results are mixed ()
3D CMR shines as diagnostic tool for detecting CAD ()
Statins are cost-effective for CVD prevention in older adults ()
Hospital settles cardiologists’ whistleblower suit for $21.75M ()
A toast to white wine as cardiac booster ()
Physicians cite interoperability issues, EHR concerns in survey ()
Synergy clears noninferiority bar in EVOLVE II ()
Solitaire stent retriever reduces disability after stroke ()
VasCore Training & Education Center (VTEC) opens in downtown Boston ()
Medtronic begins enrollment in feasibility study of Valiant ‘Mona LSA’ branch thoracic stent graft system ()
Diabetes patients undergoing CABG have increased risk of death ()
Harvard Clinical Research Institute (HCRI) named data analytic center For the American College Of Cardiology's (ACC) Pinnacle Registry of atrial fibrillation ()
Potential harms from cath lab radiation may include heart disease ()
More than 75% of hospitals use EHR systems ()
Cardinal Health settles case over stress test agents for $26.8M ()
S-ICDs prove safe and effective at 2 years ()
Few consumers use healthcare price and quality data ()
Trouble in Oz: Some docs want him out ()
Heart failure incidence dips 37.5% over 10 years ()
CHD experts recommend exercise, risk factor control for older adults ()
Similar efficacy for embolic protection devices in carotid artery stenting ()
Siemens Healthcare introduces ultrasound system for rapid imaging in an emergency setting ()
Shared risk factors lead to diabetes, heart disease and cancer, says major AACR symposium ()
FDA clears way for more versatile atherectomy device ()
Health spending growth much lower than expected ()
N.Y. cardiologist maintains innocence in murder-for-hire plot ()
Levi Watkins, pioneering cardiac surgeon, dies ()
Docs in a fix: Some will see Medicare fee cuts for a while ()
AMA names 2 cardiologists to head RUC, code committees ()
Healthcare data breaches affect 29M records from 2010 to 2013 ()
From paralysis to progress ()
OriGen Biomedical recalls ECMO catheters ()
N.Y. police arrest cardiologist in murder-for-hire plot ()
NIH launches largest trial to date for HIV-related cardiovascular disease ()
Exercise during pregnancy may benefit fetal hearts ()
Physician advocates in D.C. eager to shift focus to quality ()
FDA approves ivabradine for heart failure patients ()
FDA advisory committee recommends approval of cangrelor ()
Corporate wellness programs lacking in CVD and stroke prevention initiatives ()
Uninsured rate in U.S. is lowest in 7 years ()
ACC, SCAI rejoice as Senate repeals SGR ()
FDA panel favors heart failure warning on saxagliptin’s labeling ()
Involving pharmacists may boost adherence to NOACs ()
Medtronic announces CE mark of world’s smallest pacemaker, Micra Transcatheter Pacing System ()
Quality metrics not always based on evidence, peer-reviewed methods ()
HIMSS.15: IBM partners with Medtronic, Apple, J&J to launch Watson platform ()
PROMETHEUS, ORBIT II, TRIAGE among SCAI's late-breakers ()
HIMSS.15: Health IT leaders name patient satisfaction, engagement as a top priority ()
Texas, the lone-stance state ()
25% of low-risk patients receive oral anticoagulants unnecessarily ()
High-efficiency SPECT system works, even in morbidly obese ()
Health Diagnostics Laboratory, Singulex settle kickback suits for $48.5M ()
No more being cowed by bullies ()
Taxing times ()
Red blood cell storage duration does not affect outcomes after cardiac surgery ()
Atrial fibrillation adds $4,905 to stroke costs in younger adults ()
FDA lets Direct Flow take on CoreValve ()
Sports-associated sudden cardiac arrest rare in middle-age people ()
Lipid traits may partly explain CAD risk with shortness ()
Survey: Orthopedic injuries plague half of operators ()
Hospitalization rates differ depending on antiarrhythmic drug use ()
Three skills doctors need to become effective executives ()
Top 5 Sessions at HIMSS.15 ()
Statement clarifies use of heart pumps in high-risk patients ()
400K more young adults qualify for statins under pediatric guideline ()
Medicare Advantage payments to increase 1.25% in 2016 ()
GOLD AF Registry to capture real-world insights using Medtronic Phased RF Ablation to treat patients with atrial fibrillation ()
Phenomapping analysis identifies groups of heart failure patients ()
Libidos & lipid-lowering drugs ()
FDA allows less anticoagulation with On-X valve ()
ED visits for ischemic stroke or TIA decrease 35% over decade ()
Heart monitoring service settles overbilling case for $6.4M ()
Few nursing home patients benefit from lower limb revascularization ()
FDA files supplemental New Drug Application for Boehringer Ingelheim’s Pradaxa (dabigatran etexilate mesylate) for the prophylaxis of deep venous thrombosis and pulmonary embolism after hip replacement surgery ()
CMS delays 'two-midnight' policy until April 30 ()
CMS measures to start adjusting for stroke severity in 2016 ()
A prominent endorsement for ending SGR ()
Medtronic acquires Diabeter, innovative diabetes care provider ()
Medtronic settles whistleblower suit for $4.4M ()
TAVR's growing presence ()
Global cardiovascular deaths increase more than 40% since 1990 ()
Sanford-Burnham licenses small molecule to Daiichi Sankyo for further development ()
Statement on treating patients with hypertension and heart failure ()
Analysis shows 15% of HeartWare recipients develop gastro bleeding ()
Giving patients ownership, including medical data ()
Stuck in time: Stroke centers make little headway in swift care ()
Practicing patchless ()
Robotic telestroke model takes longer but is as safe as standard care ()
Review finds fewer DVT hospitalizations with rivaroxaban ()
First use of new ablation catheter in U.S. offers improved treatment technology for millions who experience atrial fibrillation ()
Bayer HealthCare expands collaboration with Broad Institute of MIT and Harvard to develop therapies for cardiovascular disease ()
Medtronic announces new SPYRAL HTN Global Clinical Trial Program for renal denervation ()